Thibodeaux v. DISA Global Solutions, Inc.

CourtDistrict Court, M.D. Louisiana
DecidedNovember 3, 2020
Docket3:18-cv-00651
StatusUnknown

This text of Thibodeaux v. DISA Global Solutions, Inc. (Thibodeaux v. DISA Global Solutions, Inc.) is published on Counsel Stack Legal Research, covering District Court, M.D. Louisiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Thibodeaux v. DISA Global Solutions, Inc., (M.D. La. 2020).

Opinion

UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF LOUISIANA SHANE THIBODEAUX AND HEATHER CIVIL ACTION THIBODEAUX, BOTH INDIVIDUALLY AND ON BEHALF OF THEIR MINOR CHILDREN, AUBRE THIBODEAUX, SHANE THIBODEAUX, JR., AND AMIEE THIBODEAUX

VERSUS 18-651-SDD-RLB

DISA GLOBAL SOLUTIONS, INC., ET. AL.

RULING The matter before the Court is the Motion for Summary Judgment1 by Defendant DISA Global Solutions, Inc. (“DISA”). Plaintiffs Shane Thibodeaux (“Thibodeaux”) and Heather Thibodeaux both individually and on behalf of their minor children Aubre Thibodeaux, Shane Thibodeaux, Jr., and Amiee Thibodeaux (collectively “Plaintiffs”) filed an Opposition2 to this motion to which the DISA filed a Reply.3 For the following reasons, the Court finds that the DISA’s Motion4 should be GRANTED. I. BACKGROUND A. Facts B. This diversity case involves damages allegedly caused by a positive workplace drug test. Plaintiff Shane Thibodeaux (“Thibodeaux”) submitted a hair sample that tested positive for methamphetamine—a result he claims was attributable

1 Rec. Doc. No. 28. 2 Rec. Doc. No. 29. 3 Rec. Doc. No. 35. 4 Rec. Doc. No. 28. 63105 1 to DISA’s negligence.5 Thibodeaux allegedly suffered negative employment consequences when his employer, Troy Rembert, CEO of Specialty Welding and Turnarounds (“SWAT”), was made aware of the results. At issue is whether DISA, which administers the drug testing program at issue, can be held liable for its allegedly negligent acts and those of other third parties in the drug testing

chain. C. DISA developed a policy known as the DISA Contractors Consortium Hair Testing Policy (“DCCHT”).6 The DCCHT provides a standardized substance abuse policy for all “Participating Owners”7 so that when contractors and their employees move from job site to job site, the contractors do not need to re-test their employees in order to conform to the new Owner’s substance abuse policy.8 Contractors, such as Thibodeaux’s employer SWAT, enter into agreements with DISA whereby DISA administers the contractor’s substance abuse policy in accordance with the DCCHT.9 Employees of those contractors,

such as Thibodeaux, sign DISA’s Universal Membership Application Form, consenting to testing and disclosure of their drug tests to contractors and participating owners.10 While DISA may not require employees to submit to drug testing, their employers or the participating owners’ insistence on adherence to the DCCHT may compel the employee to do so.

5 Rec. Doc. No. 29. 6 Rec. Doc. No. 29-3, p. 9. 7 Defined within the DCCHT as “[A]n Owner registered with DISA for verification access, who has accepted the DCCHT Substance Abuse Policy as meeting the requirements of their individual site drug policies.” Id. at p. 25. 8 Id. at p. 9. 9 Rec. Doc. No. 29-3, p. 2–3, ¶ 18. 10 Rec. Doc. No. 28-2, p. 2; Rec Doc. No. 29-2, p. 1. 63105 2 D. If an employee tests positive for illicit substances, that employee is noncompliant with the DCCHT.11 Noncompliance with the DCCHT is punished with the classification “Inactive” in DISA’s system, which gives contractors and participating owners the right to deny the “Inactive” employee access to a job site.12 “Inactive” status thus carries negative employment consequences. DISA

will return an employee to “Active” status after completion of DISA’s “Return- to-Duty Process.”13 However, prior “Inactive” status can preclude employment at “zero tolerance” worksites, as it allegedly did for Thibodeaux.14 E. A thorough understanding of the drug testing process is necessary. The first step in the testing process is the collection of the donor’s sample.15 In this case, Gulf Coast Occupational Medicine (“Gulf Coast”) collected Thibodeaux’s hair sample.16 After collecting the sample, the collector places it in a sealed container and sends it to a laboratory for drug testing.17 In this case, Gulf Coast collected the sample and sent it to Psychemedics Laboratory (“Psychemedics”).18 If the laboratory determines that the sample is positive for

illicit substances, the results are sent to a Medical Review Officer (“MRO”) who reviews the results; and, if necessary, conducts an interview with the donor to determine if the positive result could have a legitimate explanation.19 In this

11 Rec. Doc. No. 28-2, p. 2–3; Rec Doc. No. 29-2, p. 1. 12 Rec. Doc. No. 29-3, p. 10. 13 Id. at pp. 27–30. 14 Rec. Doc. No. 29-5, p. 31; Rec. Doc. No. 29-3, p. 4. 15 Rec. Doc. No. 28-2, p. 5; Rec Doc. No. 29-2, p. 2–3. 16 Rec. Doc. No. 28-2, p. 3; Rec Doc. No. 29-2, p. 2–3. 17 Rec. Doc. No. 28-2, p. 3; Rec Doc. No. 29-2, p. 2. 18 Rec. Doc. No. 28-2, p. 6; Rec Doc. No. 29-2, p. 3. 19 Rec. Doc. No. 28-2, p. 3; Rec Doc. No. 29-2, p. 2. 63105 3 case, Psychemedics concluded that Thibodeaux’s sample was positive for methamphetamine and amphetamine and sent the results to University Services (“University”), the MRO provider.20 Dr. Harvey Forman, a certified MRO and contractor for University, reviewed Thibodeaux’s prescription history, which included a prescription for Adderall, an amphetamine.21 Dr. Forman

interviewed Thibodeaux and concluded that there was no legitimate explanation for the positive methamphetamine results; Thibodeaux contends that over-the-counter sinus and allergy medications could have caused the result.22 In any event, when the MRO determines that there is no legitimate explanation for a positive result, the MRO confirms the result and reports its conclusion to DISA; Dr. Forman did so in this case.23 Upon receipt of a positive report, DISA changed Thibodeaux’s status to “Inactive” in its database, which resulted in negative employment consequences.24 F. Pursuant to the DCCHT, Thibodeaux requested that Psychemedics perform another test on the remaining hair sample.25 Psychemedics performed an

additional test, and sent a portion of the remaining hair sample to Omega Laboratories who also performed another test.26 Each of these tests were also positive for methamphetamine, although Thibodeaux contends that the results were consistent with the use of over-the-counter allergy and sinus inhalers.27

20 Rec. Doc. No. 28-2, p. 6; Rec Doc. No. 29-2, p. 3. 21 Rec. Doc. No. 28-2, p. 6; Rec Doc. No. 29-2, p. 3. 22 Rec. Doc. No. 28-2, p. 6; Rec Doc. No. 29-2, p. 3. 23 Rec. Doc. No. 28-2, p. 4, 7; Rec Doc. No. 29-2, p. 2–3. 24 Rec. Doc. No. 29-5, p. 31; Rec. Doc. No. 29-3, p. 4. 25 Rec. Doc. No. 28-2, p. 7; Rec Doc. No. 29-2, p. 3. 26 Rec. Doc. No. 28-2, p. 7; Rec Doc. No. 29-2, p. 3. 27 Rec. Doc. No. 28-2, p. 7; Rec Doc. No. 29-2, p. 4. 63105 4 Thibodeaux claims that he had taken: Sudafed, Adderall, Flonase, Androgel, and Flexeril and that these drugs could have caused his positive result.28 G. The Parties’ Arguments H. Plaintiffs argue that summary judgment is inappropriate because genuine issues of material fact remain as to their claims for DISA’s negligence in the

drug testing process and loss of consortium. Thibodeaux asserts that several sources demonstrate DISA’s alleged duty to “ensure that its procedures are adequate to ensure that a Louisiana worker’s drug test is accurate”29:(1) Troy Rembert’s affidavit and the Master Services Agreement (“MSA”) executed by DISA and SWAT; (2) the DCCHT, due to the degree of control asserted over the testing process; (3) “applicable state and federal law,” specifically the Louisiana Drug Testing Statute (“LDTS”); and (4) Plaintiffs medical experts’ reports.30 I. Thibodeaux argues that DISA breached that duty by: (1) not requesting or requiring testing for d/l isomers31; (2) not following state and federal laws,

specifically the LDTS; (3) and not training or requiring the MRO to request d/l isomer testing for reports with positive methamphetamine results.32

28 Rec. Doc. No. 28-19, p. 1, University Services Medical Review Officer Worksheet by Randy Barnett; Rec. Doc. No.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Forsyth v. Barr
19 F.3d 1527 (Fifth Circuit, 1994)
Little v. Liquid Air Corp.
37 F.3d 1069 (Fifth Circuit, 1994)
Rivera v. Houston Independent School District
349 F.3d 244 (Fifth Circuit, 2003)
Pylant v. Hartford Life & Accident Insurance
497 F.3d 536 (Fifth Circuit, 2007)
Terry Gilmour v. Gates, McDonald & Co.
382 F.3d 1312 (Eleventh Circuit, 2004)
United States v. Diebold, Inc.
369 U.S. 654 (Supreme Court, 1962)
Adickes v. S. H. Kress & Co.
398 U.S. 144 (Supreme Court, 1970)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
RSR Corp. v. International Insurance
612 F.3d 851 (Fifth Circuit, 2010)
Reeves v. Sanderson Plumbing Products, Inc.
530 U.S. 133 (Supreme Court, 2000)
Nicholas v. Allstate Ins. Co.
765 So. 2d 1017 (Supreme Court of Louisiana, 2000)
Hanks v. Entergy Corp.
944 So. 2d 564 (Supreme Court of Louisiana, 2006)
Haskins v. State Farm Fire & Cas. Co.
612 So. 2d 990 (Louisiana Court of Appeal, 1993)
Corley v. Delaney
629 So. 2d 1255 (Louisiana Court of Appeal, 1993)
Shoemaker v. Giacalone
793 So. 2d 230 (Louisiana Court of Appeal, 2001)
Bujol v. Entergy Services, Inc.
922 So. 2d 1113 (Supreme Court of Louisiana, 2006)

Cite This Page — Counsel Stack

Bluebook (online)
Thibodeaux v. DISA Global Solutions, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/thibodeaux-v-disa-global-solutions-inc-lamd-2020.